Where the IPO stands
China’s securities regulator (CSRC) approved Unitree’s IPO registration on July 3, 2026 — 104 days after filing, unusually fast — clearing a Shanghai STAR Market listing of at least 40.45 million shares to raise about 4.2 billion yuan (~$618M), at an implied valuation around 42 billion yuan (~$5.9B) per Caixin and SCMP reporting. As of this writing no listing date or ticker is set; SCMP reported a debut “as early as late July.” If you own a Go2, G1, or R1 — or are deciding whether to buy one — the prospectus is the most detailed look inside this company anyone has had, and most of it is good news for owners.
The part that matters: this is a real, profitable business
The quiet fear with any $2,000–$14,000 robot is the company disappearing and the robot becoming
a brick. The prospectus argues hard against that: 2025 revenue of 1.7 billion yuan ($250M),
up from 392 million in 2024, and actually profitable — rare in humanoids, where listed peer
UBTech booked a ~700 million yuan loss on similar revenue. Unitree shipped about 5,500 humanoids
in 2025 (per Gasgoo, the most of any company globally) and 33,000+ quadrupeds from 2023–2025,
with quadruped consumer sales nearly quadrupling year over year. Your robot is not an orphaned
science project; it’s the volume leader’s core product.
Two owner-relevant lines in the use-of-proceeds section:
- Overseas service networks. EqualOcean’s prospectus coverage notes proceeds earmarked to “strengthen the company’s commercial and service network both in China and overseas” — localized service, technical support, and distribution. Today, US support means emailing Laikago@unitree.cc or paying a reseller premium (RoboStore, Unitree’s North American partner, charges $17,990 for the G1 that costs $13,500 direct — the difference buys US phone support and warranty handling). A funded, localized US service network is the single biggest thing an owner could ask for from this IPO.
- Manufacturing scale. A proprietary Hangzhou plant and a five-year target of 75,000 humanoids and 115,000 quadrupeds per year (per Rest of World). Scale is what keeps a $500 battery in stock three years from now.
Prices are falling, and the prospectus proves it
Unitree’s average humanoid selling price dropped from 593,000 yuan ($85,000) in 2023 to
167,000 yuan ($25,000) in 2025 — a 72% decline in two years, confirmed across Gasgoo and Rest
of World’s prospectus readings. Half the raise is earmarked for AI model training, and Q1 2026
profit fell ~53% on R&D and brand spending even as revenue grew 68%. Translation: Unitree is
spending like a company chasing volume, not margin. If you’re waiting for cheaper robots, the
IPO accelerates that; if you bought recently, expect your model to be undercut by its successor
on schedule (the H2 at $29,900 and the NVIDIA-based H2 Plus, due late 2026, already bracket the
G1 from above).
What the IPO does not fix
Warranties stay short and thin. Unitree’s official warranty policy publishes conditions but no durations; the durations come from reseller pages — Go2 Air 6 months, Go2 Pro 12 months, G1 base and R1 Basic 8 months, G1 EDU 18 months (RoboStore and Blue Skies listings, checked 2026-07-14). Opening the shell voids it, the official shop accepts no returns, and you pay shipping to the service center. Nothing in the prospectus promises better terms.
Parts access is already decent — direct from shop.unitree.com — and that’s the baseline, not an IPO upgrade: Go2 batteries from $500, R1 battery $500, chargers from $100, controllers $300, joint motors from $369, LiDAR units from $249 (all checked 2026-07-14). Factor shipping ($300–$1,200 on robots, buyer handles US customs) into any repair-vs-replace math.
The US-China risk is real and Unitree says so itself. The prospectus flags trade policy, possible US Entity List designation, and Nvidia chip dependence as risks; overseas sales exceed 35% of revenue, and CyberScoop reports US robotics executives urging Congress to block federal purchases of Chinese-made robots. For a US owner the realistic downside isn’t the robot stopping — it’s parts import friction, tariff pass-through, and app-store or firmware complications if relations sour. That risk survives the IPO untouched.
Our read
For owners, the IPO is mostly de-risking: the maker of your robot is profitable, shipping at volume, and about to raise $618M partly to build the overseas support it conspicuously lacks. For buyers, it’s a timing signal: prices are trending down fast and successor models are coming, so buy for what the robot does now, not its resale value. And for either, the practical watch items are the listing date, any announced US service expansion, and — for anyone doing government-adjacent work — the congressional procurement fight. We’ll update the robot pages as warranty or parts terms actually change.